Access to Hematopoietic Stem Cell Transplantation.

The article offers information on a study which examined whether the employment of hematopoietic stem cell transplantation (HCT) to treat leukemia, lymphoma or multiple myeloma (MM) differs by race and sex. Data analyzed were from the Surveillance, Epidemiology and End Results (SEER) cancer registry between 1997 and 2002 and U.S. census reports for 2000. A discussion on the research findings is detailed. It concludes that Caucasians more often receive HCT and that African Americans have lower incidences of both autologous and allogeneic HCT.